Trifluoroacetic acid → HCID 178521830, compound
Reaction equation
C(O)(C(F)(F)F)=O.[F:8][C:9]1([F:48])[CH2:14][CH2:13][CH:12]([C:15]([NH:17][C:18]2[CH:19]=[C:20]3[C:24](=[CH:25][CH:26]=2)[N:23](C2CCCCO2)[N:22]=[C:21]3[C:33]2[NH:37][C:36]3[CH:38]=[CH:39][C:40]([N:42]4[CH2:47][CH2:46][O:45][CH2:44][CH2:43]4)=[CH:41][C:35]=3[N:34]=2)=[O:16])[CH2:11][CH2:10]1>C(Cl)Cl>[F:48][C:9]1([F:8])[CH2:10][CH2:11][CH:12]([C:15]([NH:17][C:18]2[CH:19]=[C:20]3[C:24](=[CH:25][CH:26]=2)[NH:23][N:22]=[C:21]3[C:33]2[NH:37][C:36]3[CH:38]=[CH:39][C:40]([N:42]4[CH2:47][CH2:46][O:45][CH2:44][CH2:43]4)=[CH:41][C:35]=3[N:34]=2)=[O:16])[CH2:13][CH2:14]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
TFA (0.082 mL, 1.063 mmol) was added to a solution of 4,4-difluoro-N-(3-(5-morpholino-1H-benzo[d]imidazol-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-yl)cyclohexanecarboxamide (6 mg, 10.63 μmol) in CH2Cl2 (5 mL). The reaction mixture was stirred overnight at room temperature, and the solvent was removed in vacuo. Purification by flash column chromatography (5% CH3OH/CH2Cl2) afforded the title compound (4 mg) as a solid. 1H NMR: (400 MHz, CD3OD): δ 8.46 (s, 1H), 7.69 (m, 1H), 7.57 (m 2H), 7.18 (d, 1H, J=1.6 Hz), 7.07 (dd, 1H, J=2.0 and 8.8 Hz), 3.88 (m, 4H), 3.18 (m, 4H), 2.55 (m, 1H), 2.17 (m, 2H), 2.01 (m, 2H), 1.96-1.83 (m, 4H); ESI-MS [M+H]+: 481.28.
Workup
- customthe solvent was removed in vacuo
- customPurification by flash column chromatography (5% CH3OH/CH2Cl2)
Sources & evidence
- ORD record
- ord-c0571065551246e2b77cc0b62be5e66e
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08569511B2
Reaction notes
Loading…